Buy Full Version
"Global Beta-Alanine Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Global Beta-Alanine Market - Opportunity Analysis and Industry Forecast, 2019-2026

Renewable, Speciality and fine chemicals	MA_182917	Pages: NA	Dec 2019 \| 1197 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Beta-alanine also referred as 3-aminopropanoic acid is a non-essential, naturally occurring beta amino acid formed through degradation of carnosine and dihydrouracil. It is industrially produced as a result of reaction between ammonia and beta-propiolactone.

It is available in powdered form in the market and is soluble in water, ethanol and methanol. Beta-alanine is utilized as a food additive for imitation of mushroom & beef flavours and to fortify flavouring in gravies & other substances. It is also used for enhancing exercise capacity & athletic performance, improving physical functioning in elder population and building lean muscle mass.

Increasing awareness regarding protein health benefits among youth and rising importance of active lifestyles are major factors which drive the growth of beta-alanine market. Growth in pharmaceutical sector and rapid urbanization are other factors which supplement market growth.

Asia-Pacific is expected to register substantial growth owing to increasing disposable incomes and rising adoption of westernized lifestyle in emerging economies such as China and India. High dose of beta-alanine can cause taurine deficiency and paresthesia, a potentially uncomfortable tingling of skin which usually affect face, abdomen & chest. This can hinder the market growth.

However, rising applications of beta-alanine across various end-user industries and growing number of individuals seeking to participate in sports are factors expected to provide potential growth opportunities for market expansion.

The report segments the beta-alanine market on the basis of product type, end-use industry and geography. Based on product type, it is divided into food grade beta-alanine, pharmaceutical grade beta-alanine, feed grade beta-alanine and others. On the basis of end-use industry, the market is bifurcated into food & beverage, pharmaceutical, personal care, animal feed and chemical. Geographical breakdown of the market includes North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Anhui Huaheng Biotechnology Co., Ltd., Haolong Biotechnology Co. Ltd., Natural Alternatives International, Inc., Shandong Yangcheng Biotech Co., Ltd., Shanghai Hope Industry Co., Ltd., Wuhan Microsen Technology Co., Ltd., Xinfa Pharmaceutical Co., Ltd., Yangzhou Baosheng Bio-Chemical Co. Ltd., Yuki Gosei Kogyo Co., Ltd., and Zhangjiagang Specom Biochemical Co., Ltd is also provided in the report.

Key Benefits

This report provides a quantitative analysis of the current trends and estimations from 2017 to 2023 of the global beta-alanine market to identify the prevailing market opportunities.
Major countries in each region are mapped according to individual market revenue.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
An in-depth analysis of current research & clinical developments within the market is provided with key dynamic factors.
Key players and their key developments in the recent years are listed.

Beta-alanine Market Key Segments:

By Product Type

Food Grade Beta-Alanine
Pharmaceutical Grade Beta-Alanine
Feed Grade Beta-Alanine
Others

By End-Use Industry

Food & Beverage
Pharmaceutical
Personal Care
Animal Feed
Chemical

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

CHAPTER 4 GLOBAL BETA-ALANINE MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FOOD GRADE BETA-ALANINE

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PHARMACEUTICAL GRADE BETA-ALANINE

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. FEED GRADE BETA-ALANINE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. OTHERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 GLOBAL BETA-ALANINE MARKET, BY END-USE INDUSTRY

5.1. OVERVIEW

5.1.1. Key market trends
5.1.2. Key growth factors and opportunities
5.1.3. Market size and forecast

5.2. FOOD & BEVERAGE

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.3. PHARMACEUTICAL

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.4. PERSONAL CARE

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.5. ANIMAL FEED

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.6. CHEMICAL

5.6.1. Key market trends
5.6.2. Key growth factors and opportunities
5.6.3. Market size and forecast

CHAPTER 6 GLOBAL BETA-ALANINE MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. Product Type
6.2.3.2. End-Use Industry

6.2.4. U.S.

6.2.4.1. Market size and forecast, by Product Type
6.2.4.2. Market size and forecast, by End-Use Industry

6.2.5. Canada

6.2.5.1. Market size and forecast, by Product Type
6.2.5.2. Market size and forecast, by End-Use Industry

6.2.6. Mexico

6.2.6.1. Market size and forecast, by Product Type
6.2.6.2. Market size and forecast, by End-Use Industry

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Product Type
6.3.3.2. End-Use Industry

6.3.4. UK

6.3.4.1. Market size and forecast, by Product Type
6.3.4.2. Market size and forecast, by End-Use Industry

6.3.5. Germany

6.3.5.1. Market size and forecast, by Product Type
6.3.5.2. Market size and forecast, by End-Use Industry

6.3.6. France

6.3.6.1. Market size and forecast, by Product Type
6.3.6.2. Market size and forecast, by End-Use Industry

6.3.7. Spain

6.3.7.1. Market size and forecast, by Product Type
6.3.7.2. Market size and forecast, by End-Use Industry

6.3.8. Italy

6.3.8.1. Market size and forecast, by Product Type
6.3.8.2. Market size and forecast, by End-Use Industry

6.3.9. Rest of Europe

6.3.9.1. Market size and forecast, by Product Type
6.3.9.2. Market size and forecast, by End-Use Industry

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Product Type
6.4.3.2. End-Use Industry

6.4.4. China

6.4.4.1. Market size and forecast, by Product Type
6.4.4.2. Market size and forecast, by End-Use Industry

6.4.5. Japan

6.4.5.1. Market size and forecast, by Product Type
6.4.5.2. Market size and forecast, by End-Use Industry

6.4.6. India

6.4.6.1. Market size and forecast, by Product Type
6.4.6.2. Market size and forecast, by End-Use Industry

6.4.7. Australia

6.4.7.1. Market size and forecast, by Product Type
6.4.7.2. Market size and forecast, by End-Use Industry

6.4.8. South Korea

6.4.8.1. Market size and forecast, by Product Type
6.4.8.2. Market size and forecast, by End-Use Industry

6.4.9. Rest of Asia-Pacific

6.4.9.1. Market size and forecast, by Product Type
6.4.9.2. Market size and forecast, by End-Use Industry

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Product Type
6.5.3.2. End-Use Industry

6.5.4. Brazil

6.5.4.1. Market size and forecast, by Product Type
6.5.4.2. Market size and forecast, by End-Use Industry

6.5.5. South Africa

6.5.5.1. Market size and forecast, by Product Type
6.5.5.2. Market size and forecast, by End-Use Industry

6.5.6. Saudi Arabia

6.5.6.1. Market size and forecast, by Product Type
6.5.6.2. Market size and forecast, by End-Use Industry

6.5.7. Rest of LAMEA

6.5.7.1. Market size and forecast, by Product Type
6.5.7.2. Market size and forecast, by End-Use Industry

CHAPTER 7 COMPANY PROFILES

7.1. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. HAOLONG BIOTECHNOLOGY CO. LTD.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. NATURAL ALTERNATIVES INTERNATIONAL, INC.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. SHANDONG YANGCHENG BIOTECH CO., LTD.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. SHANGHAI HOPE INDUSTRY CO., LTD.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. WUHAN MICROSEN TECHNOLOGY CO., LTD.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. XINFA PHARMACEUTICAL CO., LTD.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. YUKI GOSEI KOGYO CO., LTD.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285, Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry